Skip to Content Skip to Content

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2695 Results
New Breast Cancer Drug May be Effective against Other Types of Cancer, Abramson Cancer Center Experts Find

New Breast Cancer Drug May be Effective against Other Types of Cancer, Abramson Cancer Center Experts Find

Palbociclib, a new oral drug whose efficacy in combating breast cancer has been demonstrated alone and in combination with endocrine therapy, also has potential to combat other types of cancer, according to a literature review and additional original research conducted by experts at the

Steve Graff

T Cells That Recognize HER2 Receptor May Be Key to Preventing HER2+ Breast Cancer Recurrence, Penn Study Finds

T Cells That Recognize HER2 Receptor May Be Key to Preventing HER2+ Breast Cancer Recurrence, Penn Study Finds

Recurrence of HER2-positive breast cancer after treatment may be due to a specific and possibly cancer-induced weakness in the patient’s immune system – a weakness that in principle could be corrected with a HER2-targeted vaccine – according to a new study from the Perelman School of Medicine at the University of Pennsylvania. Results of the study show that T cells from patien

Katie Delach

Penn's Anil K. Rustgi Receives American Cancer Society's Research Professor Award

Penn's Anil K. Rustgi Receives American Cancer Society's Research Professor Award

Anil K. Rustgi, MD, chief of Gastroenterology in the Perelman School of Medicine at the University of Pennsylvania, is once again the recipient of a prestigious Research Professor Award from the American Cancer Society (ACS).

Lee-Ann Donegan

Penn Researchers Use Network Science to Help Pinpoint Source of Seizures

Penn Researchers Use Network Science to Help Pinpoint Source of Seizures

For the third of all epilepsy patients who don’t respond to medication, an alternative is to locate the small cluster of neurons that act as the seed of a seizure’s aberrant electrical activity and surgically remove it. Unfortunately, such surgeries often fail to bring any relief.

Evan Lerner , Lee-Ann Donegan

Kindness, Charitable Behavior Influenced by Amygdala, Penn Research Reveals

Kindness, Charitable Behavior Influenced by Amygdala, Penn Research Reveals

The amygdala, a small structure at the front end of the brain’s temporal lobe, has long been associated with negative behaviors generally, and specifically with fear. But new research from Michael Platt, the James S.

Michele W. Berger

Aspirin Use Does Not Improve Outcomes for Cancer Patients, but May Lower Breast Tissue Density, Allowing for Earlier Detection, Two Penn Studies Find

Aspirin Use Does Not Improve Outcomes for Cancer Patients, but May Lower Breast Tissue Density, Allowing for Earlier Detection, Two Penn Studies Find

Whether aspirin may help prevent or reduce the risk of breast cancer remains a hotly debated research question. While past studies have indicated a potential benefit, most recently in hormone receptor-positive breast cancers, one new study from Penn Medicine suggests otherwise.

Katie Delach

Counseling Paired With Comprehensive Genetic Cancer Screening May Increase Knowledge and Decrease Anxiety Among At-Risk Patients, Penn Study Finds

Counseling Paired With Comprehensive Genetic Cancer Screening May Increase Knowledge and Decrease Anxiety Among At-Risk Patients, Penn Study Finds

Many BRCA 1/2-negative patients choose to proceed with comprehensive testing for genetic mutations that increase cancer risk, and when presented with counseling before and after testing, most make informed decisions and experience decreased levels of anxiety, according to new research from the Perelman School of Medicine at the University o

Katie Delach

Penn Study Points to Economic and Racial Barriers That Impact the Treatment of Psoriasis

Penn Study Points to Economic and Racial Barriers That Impact the Treatment of Psoriasis

In the first known study to examine the prevalence and treatment of psoriasis in older Americans, experts from the Perelman School of Medicine at the University of Pennsylvania have found that black patients receiving Medicare are less likely to receive biologic therapies –medications derived from human or animal cells or tissues – for the treatment of m

Katie Delach